135 related articles for article (PubMed ID: 16363049)
1. FDA notifications. FDA provides important information for clinicians serving hurricane victims.
AIDS Alert; 2005 Nov; 20(11):129. PubMed ID: 16363049
[No Abstract] [Full Text] [Related]
2. FDA notifications. Adult treatment guidelines updated.
AIDS Alert; 2005 Nov; 20(11):130-1. PubMed ID: 16363050
[No Abstract] [Full Text] [Related]
3. FDA notifications. Pediatric HIV infection guidelines for use of ARTs are revised.
AIDS Alert; 2008 Apr; 23(4):46-7. PubMed ID: 19255980
[No Abstract] [Full Text] [Related]
4. FDA notifications. Revised guidelines for pregnant women.
AIDS Alert; 2007 Dec; 22(12):141. PubMed ID: 18411483
[No Abstract] [Full Text] [Related]
5. FDA notifications. Changes to ART guidelines detailed by the FDA.
AIDS Alert; 2008 Mar; 23(3):33-4. PubMed ID: 18663777
[No Abstract] [Full Text] [Related]
6. FDA notifications. Pediatric HIV infection guidelines updated.
AIDS Alert; 2005 Jul; 20(7):83. PubMed ID: 16110564
[No Abstract] [Full Text] [Related]
7. FDA notifications. New antiretroviral guidelines issued.
AIDS Alert; 2005 Jan; 20(1):11-2. PubMed ID: 15717358
[No Abstract] [Full Text] [Related]
8. FDA guidelines revised for combination HIV therapies.
AIDS Policy Law; 2004 Jun; 19(10):2. PubMed ID: 15202412
[No Abstract] [Full Text] [Related]
9. FDA notifications. ART guidelines for adults & adolescents are revised.
AIDS Alert; 2010 Jan; 25(1):10-12. PubMed ID: 20143504
[No Abstract] [Full Text] [Related]
10. FDA notifications. New pediatric guidelines by NIH, CDC.
AIDS Alert; 2009 Oct; 24(10):117-8. PubMed ID: 20034139
[No Abstract] [Full Text] [Related]
11. FDA notifications. DHHS panel releases new ART guidelines.
AIDS Alert; 2011 Mar; 26(3):34-5. PubMed ID: 21539042
[No Abstract] [Full Text] [Related]
12. FDA notifications. FDA draft guidance on Hepatitis C/HIV coinfection.
AIDS Alert; 2010 Nov; 25(11):129-30. PubMed ID: 21128355
[No Abstract] [Full Text] [Related]
13. Misinformation in HIV/AIDS care. There's more than one way to skin a virus.
Sharp M
Posit Aware; 2006; 17(1):14-6. PubMed ID: 16475268
[No Abstract] [Full Text] [Related]
14. FDA notifications. FDA grants approval for raltegravir.
AIDS Alert; 2009 Apr; 24(4):46-8. PubMed ID: 19382366
[No Abstract] [Full Text] [Related]
15. New HIV treatment guidelines give more advice.
James JS
AIDS Treat News; 2003 Jul; (393):4. PubMed ID: 14679925
[TBL] [Abstract][Full Text] [Related]
16. HIV treatment series. Part 4 of 4. Decisions, decisions--starting or switching anti-HIV therapy.
McGuire S
Posit Aware; 2003; 14(3):31-6. PubMed ID: 12866490
[No Abstract] [Full Text] [Related]
17. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
[No Abstract] [Full Text] [Related]
18. FDA notifications. Pediatric HIV infection guidelines are revised.
AIDS Alert; 2008 Oct; 23(10):114-5. PubMed ID: 18935684
[No Abstract] [Full Text] [Related]
19. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
[No Abstract] [Full Text] [Related]
20. The ninth annual HIV drug guide.
Posit Aware; 2005; 16(1):21-47. PubMed ID: 17390504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
